[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filing a Form 144 to report a proposed Rule 144 sale. The notice shows 375,000 shares of Common stock to be sold through Morgan Stanley Smith Barney LLC on 08/19/2025 on NASDAQ, with an aggregate market value of $36,300,000. The filer reports 370,470,348 shares outstanding. The shares were acquired as Founders Shares on 11/13/2017. The filer indicates no securities sold in the past three months and includes the customary representation that they are not aware of undisclosed material adverse information.

Positive

• Full Rule 144 disclosure provided including broker, acquisition details, proposed sale date, and aggregate market value
• Filer reports no securities sold in the past three months, indicating this is not part of recent frequent disposals

Negative

• Insider proposes to sell 375,000 founder shares, which could be interpreted by some market participants as insider liquidity
• Aggregate market value is $36,300,000, which may attract investor attention despite representing ~0.10% of shares outstanding

Insights

Securities Analyst

TL;DR: A Rule 144 sale of 375,000 founder shares is disclosed; size is modest relative to outstanding stock and is a routine insider liquidity event.

The filing documents a proposed sale of 375,000 common shares via Morgan Stanley on 08/19/2025, acquired as founders shares in 2017. Against 370,470,348 shares outstanding, the position represents roughly 0.10% of the outstanding float, indicating the sale is unlikely to materially affect market supply. The filer also reports no sales in the past three months, which suggests this is an isolated disclosure rather than part of frequent insider disposition.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signature attestation about material information is included.

The Form 144 includes required elements: broker name and address, acquisition date and nature (Founders Shares, 11/13/2017), proposed sale date, and aggregate market value. The filer affirms they are unaware of undisclosed material adverse information and notes no sales in the prior three months. From a governance standpoint, the filing meets procedural disclosure standards for an insider sale under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	375000	36300000.00	370470348	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			375000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeave's (CRWV) Form 144 disclose?

The filing discloses a proposed sale of 375,000 common shares through Morgan Stanley on 08/19/2025 on NASDAQ, with an aggregate market value of $36,300,000.

When were the shares being sold originally acquired?

The shares were acquired as Founders Shares on 11/13/2017.

How large is the proposed sale relative to CoreWeave's outstanding shares?

The filing lists 370,470,348 shares outstanding; the 375,000 shares represent roughly 0.10% of outstanding shares.

Has the filer sold other CoreWeave securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.